Ether et Impuretés

6-Bromo-2-ethoxy-3-(phenylmethyl)quinoline

(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-2-yl)-1-phenylbutan-2-ol

N-Ethyl tadalafil

(4R,4'R)-2,2'-(Cyclopropane-1,1-diyl)bis(4-isopropyl-4,5-dihydrooxazole)

(Tetrahydropyran-3-yl)methanol

2-Cyano-3-[1-(2-methoxyethyl)-2,5-dimethyl-1h-pyrrol-3-yl]prop-2-enoic acid

(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-(((3S,4S,5S,6S)-4-(dimethylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-16-ethyl-4-hydroxy-7-(2-hydroxyethyl)-15-(hydroxymethyl)-5,9,13-trimethyloxacyclohexadeca-11,13-diene-2,10-dione

(R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate

INCB 3284 enantiomer 1

Bromo-PEG5-azide

Carboxy-PEG4-phosphonic acid

lithium 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoate dihydrate

(S)-methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate

(S)-1-phenylethanamine (R)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate

(1S,2S,4R)-1-methyl-2-morpholino-4-(prop-1-en-2-yl)cyclohexanol oxalate

(S)-N-((1S,2R)-2-(prop-2-yn-1-yloxy)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-2-carboxamide 2,2,2-trifluoroacetate

Fmoc-PEG2-C2-NHS ester

K-Ras ligand-Linker Conjugate 4

Bromoacetamido-PEG2-C2-acid

Thiol-PEG3-acid